March 22, 2013 — Abbott announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
March 20, 2013 — Svelte Medical Systems announced treatment of the first patient in the DIRECT II (Direct Implantation ...
March 20, 2013 — TherOx Inc. announced the initiation of its multicenter investigational device exemption (IDE) pilot cl ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
March 19, 2013 — Terumo Interventional Systems expanded its family of Heartrail III Coronary Guiding Catheters to ...
Ajay Kirtane, M.D., SD, chief academic officer at Columbia University Medical Center/New York Presbyterian Hospital ...
The American College of Cardiology (ACC) 2013 Scientific Session Committee Chairman Miguel Quinones, M.D., explains some ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
DAIC Editor Dave Fornell explains his choices for the most innovative new technology on the expo floor at the American ...
March 12, 2013 — Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and ...
March 11, 2013 — Philips Healthcare and Infraredx Inc. announced the availability of a new solution that enables ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
March 8, 2013 — Boston Scientific Corporation has begun the launch of its 0.035-inch and 0.018-inch Rubicon Support Cath ...
March 7, 2013 — Philips Healthcare announced it has received 510(k) clearance from the U.S. Food and Drug Administration ...
March 7, 2013 — Mercator MedSystems Inc. announced it has received CE mark approval to market its Cricket and Bullfrog ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
March 7, 2013 — Cardiovascular Systems Inc. (CSI) presented three-year data from its ORBIT I feasibility study of ...
Oklahoma Heart Hospital (OHH), Oklahoma’s first dedicated heart hospital, has excelled at creating quality outcomes ...
Over the past decade in the United States, there has been growing interest in transradial artery percutaneous access as ...
March 22, 2013